CAAS Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-44,929
| Closed | -$5.82M | – | 522 |
|
|
2022
Q4 | $5.82M | Buy |
44,929
+195
| +0.4% | +$25.3K | 0.35% | 17 |
|
|
2022
Q3 | $4.95M | Sell |
44,734
-29,326
| -40% | -$3.24M | 0.24% | 34 |
|
|
2022
Q2 | $5.55M | Buy |
74,060
+8,260
| +13% | +$619K | 0.28% | 27 |
|
|
2022
Q1 | $5.14M | Sell |
65,800
-22,630
| -26% | -$1.77M | 0.21% | 31 |
|
|
2021
Q4 | $7.96M | Buy |
88,430
+5,986
| +7% | +$539K | 0.19% | 37 |
|
|
2021
Q3 | $7.62M | Buy |
82,444
+4,700
| +6% | +$435K | 0.15% | 48 |
|
|
2021
Q2 | $6.04M | Buy |
77,744
+24,266
| +45% | +$1.89M | 0.1% | 72 |
|
|
2021
Q1 | $3.99M | Buy |
+53,478
| New | +$3.99M | 0.04% | 185 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 611 |
|